Protagenic Therapeutics, Inc.
PTIX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001022899
In the last 90 days, Protagenic Therapeutics, Inc. insiders filed 7 open-market purchases and 0 sales; 2 institutions reported holding it in 13F filings for Q2 2026, worth $25.4K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Protagenic Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 4 | 2 | −2 |
| Shares | 66.9K | 66.8K | −117 (−0.2%) |
| Value | $44.4K | $25.4K | −$19.0K (−42.8%) |
New holders (0)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
None.
Sold out (2)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CoreCap Advisors, LLC | 100 | $68 |
| United Financial Planning Group LLC | 17 | $12 |